Clinical Scorecard: CT-Based Assessment of Malignancy Risk in Part-Solid Pulmonary Nodules Utilizing Vascular Distortion and Interruption Analysis

At a Glance

Key Highlights

• Qualitative CT assessment of vascular interruption and distortion significantly improves malignancy prediction in PSNs.
• Malignant PSNs show higher prevalence of vascular patterns IV (interruption) and V (distortion).
• Model 2, incorporating vascular types IV and V, demonstrated superior predictive performance.
• Malignancy rates in PSNs range from 10 to 60%, necessitating accurate differentiation.
• Emerging imaging biomarkers are essential for improved diagnostic specificity.

Guideline-Based Recommendations

Diagnosis

• Utilize qualitative vascular analysis alongside conventional morphological features for malignancy prediction.

Management

• Consider preoperative risk stratification based on CT vascular features.

Monitoring & Follow-up

• Regular follow-up of PSNs based on size, solid component, and growth over time.

Risks

• Balancing risks of unnecessary invasive procedures against delayed lung cancer diagnosis.

Patient & Prescribing Data

Patients with surgically resected part-solid pulmonary nodules

Integration of vascular analysis can enhance clinical decision-making.

Clinical Best Practices

• Incorporate qualitative and quantitative vascular assessments in the evaluation of PSNs.
• Utilize decision curve analysis for clinical utility assessment of predictive models.

References

• Fleischner Society Guidelines
• Lung Cancer Screening Recommendations